Research Article
Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience
Figure 2
Progression-free survival Kaplan–Meier curves. Progression-free survival is stratified by pCR status (a) and ER status (b). Estimated 2-year PFS in each subgroup is provided with respective hazard ratios and values.
(a) |
(b) |